Effect of VIrtual Reality Spectacles on the Management of Pain and Anxiety (LURVIDOC)

Poissy-Saint Germain Hospital

Status: Unknown

Conditions: Cancer

Treatments: Device: virtual reality Bliss Solution

Study type: Interventional

Funder types: Other

Identifiers

NCT05015790

2020-A00132-37

Details and patient eligibility

About

To assess the contribution of the use of virtual reality glasses on the pain perceived by patients during the installation of an ICP in the operating room under local anesthesia in the patient newly diagnosed with cancer

Full description

The insertion of an implantable catheter chamber (ICH) is indicated in the case of prolonged or repeated infusions, particularly when the products injected are toxic to the venous walls, as is the case with cancer chemotherapy.

The insertion of a ICH is carried out in the operating theatre, usually under local anaesthesia. Although this operation is potentially painful and stressful, the question of its perception by the patient has not yet been addressed, nor the relevance of using non-invasive devices to alleviate the pain felt by the patient.

Among the proposals, virtual reality glasses Bliss Solution would be likely to improve patient management when a ICH is performed under local anaesthesia in the operating theatre.

The evaluation will be made on the contribution of the use of the Bliss Solution virtual reality glasses in the management of pain during the installation of an ICH under local anesthesia in the operating room.

Enrollment: 120 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Adult patient over 18 years of age
• Patient suffering from a cancerous pathology
• Patient taken care of for the installation of the ICH

Exclusion criteria

• Patient does not speak and understand French
• Patient who has had a previous ICH installation
• Patient with cognitive impairment
• Patient with pain perception disorder

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

120 participants in 2 patient groups

use of virtual reality Bliss Solution

Experimental group

Description:

in the experimental arm the patient will receive the usual practice associated with a virtual reality session (20 minutes renewable) in a world chosen with the patient beforehand

Treatment:

Device: virtual reality Bliss Solution

current practice, without Bliss Solution

No Intervention group

Description:

patient will receive the usual practice, local anesthesia